Abiomed (ABMD) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for ABMD stock
Abiomed, Inc. Analysis
ABMD Stock News


Popular stocks:
Suncor Energy
Square
Tilray
QUALCOMM

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Pure Storage
Desktop Metal
US Foods Holding
Qurate Retail
PennyMac Financial Services
Hycroft Mining Holding
Viatris
Booking
PagerDuty
CRISPR Therapeutics


Financial News

Popular Stocks Analysis

Helpful Highlights
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. ABMD

Abiomed (ABMD) Stock Forecast for 2024–2028. Sell or Buy?

Updated: May 9, 2024 (10:50)

Sector: Healthcare

The share price of Abiomed, Inc. (ABMD) now

This company is DELISTED
Latest session on the 3rd of January for
Abiomed, Inc. is negative
Trading Volume: 258
Open: 381.02 /  High: 381.02 /  Low: 381.02
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Abiomed stocks, the 50-day moving average is the support level today.

For Abiomed stocks, the 200-day moving average is the support level today.

Are you interested in Abiomed, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abiomed stock price in 2024, 2025, 2026, 2027, 2028. How much will one Abiomed share be worth in 2024 - 2028?

When should I take profit in Abiomed stock? When should I record a loss on Abiomed stock? What are analysts' forecasts for Abiomed stock? What is the future of Abiomed stock? We forecast Abiomed stock performance using neural networks based on historical data on Abiomed stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Abiomed stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abiomed shares. This happens once a day.


Historical and forecast chart of Abiomed stock

The chart below shows the historical price of Abiomed stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abiomed stock price can be found in the table below.

No data

Long-term forecasts by years.

Abiomed is a manufacturer of medical implants, including the AbioCor artificial heart and impella. The company is headquartered in Danvers, Massachusetts and has three subsidiary offices: two in Germany in Berlin and Aachen and one in Japan. Michael R. Minogue joined Abiomed in 2004 and serves as CEO, Chairman and President.

Abiomed daily forecast for a month

Date Target Pes. Opt. Vol., %
May 11 389.91 387.65 395.60 2.05
May 12 387.42 381.76 388.97 1.89
May 13 383.85 379.94 385.54 1.47
May 14 377.94 373.93 383.99 2.69
May 15 376.73 373.26 380.65 1.98
May 16 383.89 379.97 386.73 1.78
May 17 381.74 375.94 385.48 2.54
May 18 378.07 374.67 380.72 1.61
May 19 374.44 370.03 378.94 2.41
May 20 372.65 367.58 378.09 2.86
May 21 367.28 364.34 371.76 2.04
May 22 368.16 365.22 371.92 1.83
May 23 369.41 363.95 371.26 2.01
May 24 375.99 371.93 378.70 1.82
May 25 373.81 368.87 377.40 2.31
May 26 378.37 372.62 382.38 2.62
May 27 376.55 371.66 379.72 2.17
May 28 376.63 371.96 380.47 2.29
May 29 378.96 374.72 382.37 2.04
May 30 373.05 370.44 375.44 1.35
May 31 374.84 373.04 376.42 0.90
Jun 01 377.47 373.01 381.92 2.39
Jun 02 376.86 372.72 381.16 2.26
Jun 03 375.66 370.17 380.09 2.68
Jun 04 377.61 374.74 381.31 1.75
Jun 05 376.55 371.96 380.39 2.27
Jun 06 372.34 370.70 376.58 1.59
Jun 07 366.97 362.64 371.16 2.35
Jun 08 364.33 361.85 369.07 1.99
Jun 09 366.88 364.31 369.89 1.53

Abiomed Daily Price Targets


Abiomed Stock Forecast 05-11-2024.

Forecast target price for 05-11-2024: $389.91.
Positive dynamics for Abiomed shares will prevail with possible volatility of 2.011%.
Pessimistic target level: 387.65
Optimistic target level: 395.60

Abiomed Stock Forecast 05-12-2024.

Forecast target price for 05-12-2024: $387.42.
Negative dynamics for Abiomed shares will prevail with possible volatility of 1.853%.
Pessimistic target level: 381.76
Optimistic target level: 388.97

Abiomed Stock Forecast 05-13-2024.

Forecast target price for 05-13-2024: $383.85.
Negative dynamics for Abiomed shares will prevail with possible volatility of 1.454%.
Pessimistic target level: 379.94
Optimistic target level: 385.54

Abiomed Stock Forecast 05-14-2024.

Forecast target price for 05-14-2024: $377.94.
Negative dynamics for Abiomed shares will prevail with possible volatility of 2.618%.
Pessimistic target level: 373.93
Optimistic target level: 383.99

Abiomed Stock Forecast 05-15-2024.

Forecast target price for 05-15-2024: $376.73.
Negative dynamics for Abiomed shares will prevail with possible volatility of 1.940%.
Pessimistic target level: 373.26
Optimistic target level: 380.65

Abiomed Stock Forecast 05-16-2024.

Forecast target price for 05-16-2024: $383.89.
Positive dynamics for Abiomed shares will prevail with possible volatility of 1.747%.
Pessimistic target level: 379.97
Optimistic target level: 386.73

ABMD (ABMD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jun. 388.34 373.11 395.17 5.58
Jul. 392.69 376.66 414.05 9.03
Aug. 378.23 367.64 401.53 8.44
Sep. 375.81 359.88 384.23 6.34
Oct. 390.55 380.24 411.79 7.66
Nov. 411.17 386.50 430.90 10.31
Dec. 408.21 385.02 420.29 8.39
Full forecast for 2024

Abiomed forecast for this year


Abiomed Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $388.336. Pessimistic: $373.11. Optimistic: $395.17


Abiomed Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $392.685. Pessimistic: $376.66. Optimistic: $414.05


Abiomed Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $378.234. Pessimistic: $367.64. Optimistic: $401.53


Abiomed Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $375.813. Pessimistic: $359.88. Optimistic: $384.23


Abiomed Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $390.545. Pessimistic: $380.24. Optimistic: $411.79


Abiomed Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $411.166. Pessimistic: $386.50. Optimistic: $430.90


Abiomed Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $408.206. Pessimistic: $385.02. Optimistic: $420.29



Abiomed (ABMD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 408.86 383.67 431.43 11.07
Feb 408.21 391.88 418.66 6.40
Mar 413.76 387.94 428.65 9.50
Apr 401.51 380.31 425.60 10.64
May 416.93 401.25 434.27 7.60
Jun 412.93 404.01 433.74 6.85
Jul 436.71 415.75 460.47 9.71
Aug 439.16 413.51 463.75 10.83
Sep 467.61 457.14 475.84 3.93
Oct 470.98 444.60 494.72 10.13
Nov 458.55 430.67 482.39 10.72
Dec 484.96 472.93 515.22 8.21
Full forecast for 2025

Abiomed (ABMD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 470.21 456.67 499.56 8.58
Feb 459.68 447.18 487.63 8.30
Mar 442.40 430.72 456.20 5.59
Apr 456.91 446.67 473.36 5.64
May 449.23 425.87 468.28 9.06
Jun 450.67 439.13 474.83 7.52
Jul 480.23 466.79 505.97 7.74
Aug 513.66 488.18 530.92 8.05
Sep 491.47 469.84 520.56 9.74
Oct 498.94 486.56 530.87 8.35
Nov 466.21 452.41 488.59 7.40
Dec 446.07 422.52 464.27 8.99
Full forecast for 2026

Abiomed (ABMD) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 464.62 447.53 488.41 8.37
Feb 467.60 445.15 484.81 8.18
Mar 473.96 460.69 500.50 7.95
Apr 505.81 487.60 526.04 7.31
May 494.07 483.80 506.72 4.52
Jun 492.89 466.86 516.55 9.62
Jul 502.35 485.07 519.63 6.65
Aug 538.92 529.87 550.56 3.76
Sep 559.62 548.42 574.84 4.60
Oct 567.67 540.88 585.84 7.67
Nov 557.68 532.70 573.74 7.15
Dec 556.79 525.61 569.26 7.67
Full forecast for 2027

Abiomed (ABMD) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 589.31 577.99 600.15 3.69
Feb 591.66 573.20 602.55 4.87
Mar 585.98 556.45 622.55 10.62
Apr 599.11 578.98 620.68 6.72
May 590.48 556.00 610.80 8.97
Jun 629.22 600.02 650.86 7.81
Jul 655.39 615.55 680.04 9.48
Aug 658.02 635.91 678.02 6.21
Sep 673.81 650.63 709.92 8.35
Oct 650.09 620.45 664.13 6.58
Nov 668.29 647.44 681.66 5.02
Dec 620.71 591.91 654.97 9.63
Full forecast for 2028

Abiomed information and performance

Abiomed Address

N/A

Market Capitalization: N/A $

Market capitalization of the Abiomed, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABMD shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Abiomed is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

Turning Point Therapeutics, Inc. (TPTX)
Sundial Growers Inc. (SNDL)
Canopy Growth Corp. (CGC)
Rite Aid Corp. (RAD)
Thermo Fisher Scientific Inc. (TMO)
EyePoint Pharmaceuticals, Inc. (EYPT)
Nano-X Imaging Ltd. (NNOX)
Vaccinex, Inc. (VCNX)
Kiniksa Pharmaceuticals, Ltd. (KNSA)
BioXcel Therapeutics, Inc. (BTAI)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website